promising biomarkers to select patients for checkpoint inhibitor therapy in melanoma
Published 7 years ago • 92 plays • Length 5:16Download video MP4
Download video MP3
Similar videos
-
1:06
evaluating the suitability of checkpoint inhibitors with biomarkers in patients with melanoma
-
1:25
novel biomarkers of response to ici in melanoma
-
2:58
the importance of biomarkers to optimize treatment with immunotherapy for melanoma
-
3:39
foxc1 as a novel prognostic biomarker in immune checkpoint inhibitor therapy
-
2:10
using biomarkers to predict response to combination therapies in braf-mutant melanoma
-
4:26
patient selection for checkpoint inhibitor therapy and assessing response
-
1:19
dr. hamid on using biomarkers for immunotherapy in melanoma
-
1:43
dr. topalian on biomarkers for anti- pd-1 therapies in melanoma
-
2:15
cardiac biomarkers for immune checkpoint inhibitor-related myocarditis in cancer patients
-
33:17
evaluating biomarkers for response to neoadjuvant immune checkpoint blockade..
-
3:21
predictive biomarker testing for immunotherapy in melanoma
-
24:18
immunotherapy biomarkers and patient selection
-
2:12
dr. vokes on investigative biomarkers of response to checkpoint inhibitors in cancer
-
0:56
dr. antoni ribas on the search for immunotherapy biomarkers in melanoma
-
0:58
the future of immune checkpoint inhibition in melanoma
-
1:04
dr. mehnert on promising biomarkers for immunotherapy
-
1:20
resistance to immune checkpoint blockade in patients with cscc
-
0:57
how do we select the urothelial carcinoma patients who will benefit from checkpoint inhibitors?
-
1:45
mechanisms of resistance to checkpoint inhibitors in melanoma